After the close, GW Pharma (NASDAQ: GWPH) issued two press releases and hosted a conference call to review its FY18-Q1 ending 12/31/17. The company reported that the European Medicines...

We have written before about the tremendous challenges cannabis companies face when it comes to advertising and how some in the industry will turn to charitable contributions as a...